Biotech Showcase™ 2017: The financial continuum and value creation

January 18, 2017
Biotech financial markets were buffeted by the winds of macro-economic events in 2016 ranging from the Brexit vote to the unprecedented presidential election in the US. In this new year we will take stock of what we might expect for biotech investment in 2017. Venture capitalists, corporate VCs, crossover investors and I-bankers share their outlooks for the coming year.
Previous Video
Biotech Showcase™ 2017: What's ahead with the new Trump administration?
Biotech Showcase™ 2017: What's ahead with the new Trump administration?

It’s no secret that the life sciences industry has had some challenging moments with lawmakers in recent ye...

Next Video
Biotech Showcase™ 2017: Unmet needs, uncommon commitment: The shift toward investment in rare diseas
Biotech Showcase™ 2017: Unmet needs, uncommon commitment: The shift toward investment in rare diseas

Join biotech leaders, emerging innovators, investors and patient advocacy group representatives for a candi...